VitaStem (VITASTEM) Tokenomics

VitaStem (VITASTEM) Tokenomics

Discover key insights into VitaStem (VITASTEM), including its token supply, distribution model, and real-time market data.
Page last updated: 2025-10-07 16:58:21 (UTC+8)
USD

VitaStem (VITASTEM) Tokenomics & Price Analysis

Explore key tokenomics and price data for VitaStem (VITASTEM), including market cap, supply details, FDV, and price history. Understand the token's current value and market position at a glance.

Market Cap:
$ 1.85M
$ 1.85M$ 1.85M
Total Supply:
$ 10.00M
$ 10.00M$ 10.00M
Circulating Supply:
$ 3.19M
$ 3.19M$ 3.19M
FDV (Fully Diluted Valuation):
$ 5.78M
$ 5.78M$ 5.78M
All-Time High:
$ 0.5982
$ 0.5982$ 0.5982
All-Time Low:
$ 0.558558
$ 0.558558$ 0.558558
Current Price:
$ 0.581839
$ 0.581839$ 0.581839

VitaStem (VITASTEM) Information

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

VitaStem (VITASTEM) Tokenomics: Key Metrics Explained and Use Cases

Understanding the tokenomics of VitaStem (VITASTEM) is essential for analysing its long-term value, sustainability, and potential.

Key Metrics and How They Are Calculated:

Total Supply:

The maximum number of VITASTEM tokens that have been or will ever be created.

Circulating Supply:

The number of tokens currently available on the market and in public hands.

Max Supply:

The hard cap on how many VITASTEM tokens can exist in total.

FDV (Fully Diluted Valuation):

Calculated as current price × max supply, giving a projection of total market cap if all tokens are in circulation.

Inflation Rate:

Reflects how fast new tokens are introduced, affecting scarcity and long-term price movement.

Why Do These Metrics Matter for Traders?

High circulating supply = greater liquidity.

Limited max supply + low inflation = potential for long-term price appreciation.

Transparent token distribution = better trust in the project and lower risk of centralised control.

High FDV with low current market cap = possible overvaluation signals.

Now that you understand VITASTEM's tokenomics, explore VITASTEM token's live price!

VITASTEM Price Prediction

Want to know where VITASTEM might be heading? Our VITASTEM price prediction page combines market sentiment, historical trends, and technical indicators to provide a forward-looking view.

Why Should You Choose MEXC?

MEXC is one of the world's top crypto exchanges, trusted by millions of users globally. Whether you're a beginner or a pro, MEXC is your easiest way to crypto.

Over 4,000 trading pairs across Spot and Futures markets
Fastest token listings among CEXs
#1 liquidity across the industry
Lowest fees, backed by 24/7 customer service
100%+ token reserve transparency for user funds
Ultra-low entry barriers: buy crypto with just 1 USDT
mc_how_why_title
Buy crypto with just 1 USDT: Your easiest way to crypto!

Disclaimer

Tokenomics data on this page is from third-party sources. MEXC does not guarantee its accuracy. Please conduct thorough research before investing.

Please read and understand the User Agreement and Privacy Policy